These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 9459343)

  • 1. A new method for quantifying platelet deposition in flowing native blood in an ex vivo model of human thrombogenesis.
    Bossavy JP; Sakariassen KS; Barret A; Boneu B; Cadroy Y
    Thromb Haemost; 1998 Jan; 79(1):162-8. PubMed ID: 9459343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discrimination between platelet-mediated and coagulation-mediated mechanisms in a model of complex thrombus formation in vivo.
    Cadroy Y; Horbett TA; Hanson SR
    J Lab Clin Med; 1989 Apr; 113(4):436-48. PubMed ID: 2522978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the antithrombotic effect of PEG-hirudin and heparin in a human ex vivo model of arterial thrombosis.
    Bossavy JP; Sakariassen KS; Rübsamen K; Thalamas C; Boneu B; Cadroy Y
    Arterioscler Thromb Vasc Biol; 1999 May; 19(5):1348-53. PubMed ID: 10323789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Collagen induced thrombus formation at the apex of eccentric stenoses--a time course study with non-anticoagulated human blood.
    Barstad RM; Kierulf P; Sakariassen KS
    Thromb Haemost; 1996 Apr; 75(4):685-92. PubMed ID: 8743200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upstream thrombus growth impairs downstream thrombogenesis in non-anticoagulated blood: effect of procoagulant artery subendothelium and non-procoagulant collagen.
    Sakariassen KS; Weiss HJ; Baumgartner HR
    Thromb Haemost; 1991 May; 65(5):596-600. PubMed ID: 1871722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonfractionated heparin fails to inhibit arterial thrombosis in a human ex vivo thrombosis model.
    Bossavy JP; Cadroy Y; Sakariassen K; Boneu B; Barret A
    Ann Vasc Surg; 1999 Jul; 13(4):393-401. PubMed ID: 10398736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HN-11500--a novel thromboxane A2 receptor antagonist with antithrombotic activity in humans at arterial blood flow conditions.
    Roald HE; Barstad RM; Engen A; Kierulf P; Skjørten F; Sakariassen KS
    Thromb Haemost; 1994 Jan; 71(1):103-9. PubMed ID: 8165627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clopidogrel--a platelet inhibitor which inhibits thrombogenesis in non-anticoagulated human blood independently of the blood flow conditions.
    Roald HE; Barstad RM; Kierulf P; Skjørten F; Dickinson JP; Kieffer G; Sakariassen KS
    Thromb Haemost; 1994 May; 71(5):655-62. PubMed ID: 8091395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative contributions of collagen and tissue factor to thrombus formation on damaged vascular vessels: in-vitro studies with circulating blood.
    Lopez-Vilchez I; Tonda R; Hernandez RM; Navalon F; Diaz-Ricart M; Galan AM; Escolar G
    Coron Artery Dis; 2009 Sep; 20(6):392-9. PubMed ID: 19561489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental thrombosis on a collagen coated arterioarterial shunt in rats: a pharmacological model to study antithrombotic agents inhibiting thrombin formation and platelet deposition.
    Freund M; Mantz F; Nicolini P; Gachet C; Mulvihill J; Meyer L; Beretz A; Cazenave JP
    Thromb Haemost; 1993 May; 69(5):515-21. PubMed ID: 8322274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the oral anticoagulant phenprocoumon on blood coagulation and thrombogenesis induced by rabbit aorta subendothelium exposed to flowing human blood: role of dose and shear rate.
    Inauen W; Bombeli T; Baumgartner HR; Haeberli A; Straub PW
    J Lab Clin Med; 1991 Sep; 118(3):280-8. PubMed ID: 1919300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of platelet-dependent thrombosis by low molecular weight heparin (CY222): comparison with standard heparin.
    Cadroy Y; Harker LA; Hanson SR
    J Lab Clin Med; 1989 Oct; 114(4):349-57. PubMed ID: 2551985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of procoagulant activity of extracellular endothelial matrix by anti-tissue factor antibody and the synthetic peptide Arg-Gly-Asp-Val. Experiments with flowing non-anticoagulated human blood.
    Salatti JA; Anton P; Nemerson Y; Sakariassen KS
    Blood Coagul Fibrinolysis; 1993 Dec; 4(6):881-90. PubMed ID: 8148480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between endothelial tissue factor and thrombogenesis under blood flow conditions.
    Diquélou A; Dupouy D; Gaspin D; Constans J; Sié P; Boneu B; Sakariassen KS; Cadroy Y
    Thromb Haemost; 1995 Aug; 74(2):778-83. PubMed ID: 8585021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of platelet PlA polymorphism on experimental thrombus formation in man depends on blood flow and thrombogenic substrate.
    Cadroy Y; Sakariassen K; Grandjean H; Thalamas C; Boneu B; Sié P
    Thromb Haemost; 2001 Jun; 85(6):1097-103. PubMed ID: 11434691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative study of the anticoagulant and anti-thrombotic effects of unfractionated heparin and a low molecular weight heparin (Fraxiparine) in an experimental model of human venous thrombosis.
    Diquélou A; Dupouy D; Cariou R; Sakariassen KS; Boneu B; Cadroy Y
    Thromb Haemost; 1995 Nov; 74(5):1286-92. PubMed ID: 8607111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initial interactions of platelets and plasma proteins in flowing non-anticoagulated human blood with the artificial surfaces Dacron and PTFE.
    Roald HE; Barstad RM; Bakken IJ; Roald B; Lyberg T; Sakariassen KS
    Blood Coagul Fibrinolysis; 1994 Jun; 5(3):355-63. PubMed ID: 8075307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iohexol, platelet activation and thrombosis. II. Iohexol-induced platelet secretion does not affect collagen-induced or tissue-factor-induced thrombus formation in blood that is anticoagulated with heparin and aspirin.
    Sakariassen KS; Buchmann M; Hamers MJ; Stormorken H
    Acta Radiol; 1998 Jul; 39(4):355-61. PubMed ID: 9685818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antithrombotic properties of pravastatin reducing intra-thrombus fibrin deposition under high shear blood flow conditions.
    Hamada M; Sugimoto M; Matsui H; Mizuno T; Shida Y; Doi M; Fukushima H; Nishio K; Yoshioka A; Shima M
    Thromb Haemost; 2011 Feb; 105(2):313-20. PubMed ID: 21136018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet deposition induced by severely damaged vessel wall is inhibited by a boroarginine synthetic peptide with antithrombin activity.
    Badimon JJ; Weng D; Chesebro JH; Fuster V; Badimon L
    Thromb Haemost; 1994 Apr; 71(4):511-6. PubMed ID: 8052972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.